SEC Form 5 · accession 0001209191-18-021891
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maky Zanganeh
Director
Period of report
Dec 31, 2017
Accepted (ET)
Mar 28, 2018 · 3:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 13, 2017 | P | 2,000 | $11.25 | A | 13,500 | I | Immediate Family Member 1 |
| Common StockF1 | Feb 14, 2017 | P | 9,500 | $12.119 | A | 23,000 | I | Immediate Family Member 1 |
| Common StockF2 | Mar 17, 2017 | P | 2,000 | $23.93 | A | 25,000 | I | Immediate Family Member 1 |
| Common Stock | Mar 20, 2017 | P | 2,000 | $22.37 | A | 27,000 | I | Immediate Family Member 1 |
| Common Stock | Feb 13, 2017 | P | 1,000 | $10.966 | A | 6,800 | I | Immediate Family Member 2 |
| Common StockF3 | Feb 15, 2017 | P | 6,200 | $12.152 | A | 13,000 | I | Immediate Family Member 2 |
| Common Stock | Mar 20, 2017 | P | 1,000 | $22.38 | A | 14,000 | I | Immediate Family Member 2 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This is the weighted average purchase price of the shares, which ranged from $12.00 to $12.499 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F2This is the weighted average purchase price of the shares, which ranged from $23.70 to $24.16 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F3This is the weighted average purchase price of the shares, which ranged from $12.10 to $12.199 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.